FRONTEO, Inc. is a Tokyo-based data analytics and artificial intelligence company specializing in natural language processing of large volumes of unstructured text. Formerly known as UBIC, Inc., the company provides AI solutions for e-discovery, digital forensics, compliance, and enterprise knowledge management, serving clients in Japan, the United States, and other regions.
In healthcare and life sciences, FRONTEO develops AI platforms that mine scientific literature and clinical information to surface relationships among diseases, targets, and compounds. Its tools support activities such as target identification, drug repurposing hypotheses, biomarker exploration, and safety signal detection, helping researchers navigate complex data and prioritize R&D paths. These capabilities are relevant to pharmaceutical and biotech workflows connected to the chemical industry, where data-driven insights can inform discovery and development decisions.
To provide comprehensive coverage, we aggregate data and news under the name FRONTEO, encompassing the following company names, divisions, and related entities:
UBIC, Inc. and UBIC.
This list encompasses current and former names, alternate names, and key divisions associated with FRONTEO, ensuring you can easily find all relevant information under a single, unified profile.